Latest News

Radiotherapy in Older Women with Early-Stage Breast Cancer after Conserving Treatment

Radiotherapy in Older Women with Early-Stage Breast Cancer after Conserving Treatment

After breast conserving surgery, standard treatment in early-stage breast cancer is adjuvant radiotherapy and endocrine treatment.

Continuation or Reintroduction of Bevacizumab Improves Outcomes in Colorectal Cancer

Continuation or Reintroduction of Bevacizumab Improves Outcomes in Colorectal Cancer

Standard treatment for metastatic colorectal cancer (mCRC) is combination bevacizumab and fluorouracil-based chemotherapy.

Gleason Score 9-10 vs. Gleason 8 Associated with Worse Outcomes

Gleason Score 9-10 vs. Gleason 8 Associated with Worse Outcomes

Men who have a localized prostate biopsy Gleason 9-10 with definitive local therapy face worse outcomes.

Elevated C-Reactive Protein Linked with Poor Prognosis in Prostate Cancer

Elevated C-Reactive Protein Linked with Poor Prognosis in Prostate Cancer

An elevated c-reactive protein level is associated with poor prognosis in treated patients with prostate cancer.

Docetaxel and 5-Fluorouracil: Promising Novel Regimen for Advanced Gastric Cancer

Docetaxel and 5-Fluorouracil: Promising Novel Regimen for Advanced Gastric Cancer

Docetaxel and 5-fluorouracil as first-line treatment for patients with advanced gastric cancer.

Addition of Veliparib to Cyclophosphamide Ineffective for Ovarian Cancer

Addition of Veliparib to Cyclophosphamide Ineffective for Ovarian Cancer

Veliparib combined with oral cyclophosphamide showed promising clinical activity in BRCA-mutant solid tumors.

FDA Approves Imbruvica for Waldenström's Macroglobulinemia

FDA Approves Imbruvica for Waldenström's Macroglobulinemia

The FDA has approved Imbruvica (ibrutinib) for the treatment of previously treated patients with Waldenström's macroglobulinemia.

Multidisciplinary Cancer Teams Lack Information on Patients' Comborbidity

Multidisciplinary Cancer Teams Lack Information on Patients' Comborbidity

Multidisciplinary cancer team meetings need to systematically consider treatment of patients with comorbidity.

Nimotuzumab Not Clinically Efficacious in Glioblastoma

Nimotuzumab Not Clinically Efficacious in Glioblastoma

Nimotuzumab has shown promising efficacy for high grade glioma.

Increase in Biopsies with DCIS, Invasive Cancer Post-Mammogram

Increase in Biopsies with DCIS, Invasive Cancer Post-Mammogram

For mammography, there has been an increase in biopsies with diagnoses of invasive carcinoma and ductal carcinoma in situ (DCIS).

Prognostic Factors for Survival in Ewing's Sarcoma Identified

Prognostic Factors for Survival in Ewing's Sarcoma Identified

Researchers have identified certain prognostic factors for survival in patients with Ewing's sarcoma.

In Pancreatic Cancer, Blood Neutrophil-Lymphocyte Ratio Predicts Survival

In Pancreatic Cancer, Blood Neutrophil-Lymphocyte Ratio Predicts Survival

Neutrophil-lymphocyte ratio (NLR) change is a potential biomarker for survival in advanced pancreatic cancer.

Utilizing MRI/Ultrasound in Prostate Biopsy May Yield Better Results

Utilizing MRI/Ultrasound in Prostate Biopsy May Yield Better Results

Prostate biopsies that combine magnetic resonance imaging (MRI) technology with ultrasound give men better information.

Many Women with Breast Cancer Lack Knowledge of Their Condition

Many Women with Breast Cancer Lack Knowledge of Their Condition

Many women with breast cancer lack basic knowledge about their disease, such as their cancer stage and other characteristics

Smoking Increases Risk of Side Effects, Recurrence in Prostate Cancer

Smoking Increases Risk of Side Effects, Recurrence in Prostate Cancer

Smoking increases risks for side effects and recurrence in patients being treated for prostate cancer.

More News

Health Care Expenditure Slowed in US

Health sector prices explain much of difference between U.S. and other high-spending countries.

States Concerned About Higher-Than-Expected Medicaid Enrollment

Millions signing up for Medicaid to comply with federal health care law.

EHR Use More Than Doubles

Almost 80% of doctors in the United States have switched from paper to electronic health records.

Many Docs Order Unnecessary Medical Tests

Most physicians believe that doctors order too many medical tests, yet half admit to doing so themselves in response to a patient who insists, a new survey shows.

Reducing Six Risk Factors May Prevent 37 Million Deaths

Several modifiable risk factors can cut chronic disease deaths over the next 15 years.

Majority of Women Lack Accurate Knowledge of Their Own Breast Cancer Risk

Caucasian women overestimate their risk of breast cancer while African American and Hispanic women underestimate their risk, according to research presented at BCS 2013.

Survey Identifies Modifiable Barriers to Mammography Screening Among Rural US Women

A survey presented at BCS 2013 has found a number of factors that cause rural US women to avoid breast cancer screening.

Perioperative MRI of Uncertain Benefit for Women with DCIS

The benefit of perioperative MRI for women with ductal carcinoma in situ (DCIS) is "uncertain," found a study presented during BCS 2013.

Dr. Edith Perez's Recommended Abstracts at BCS 2013

ChemotherapyAdvisor.com Editorial Board member Dr. Edith Perez of the Mayo Clinic, Jacksonville, FL, recommends high impact abstracts at the Breast Cancer Symposium 2013.

Radiotherapy for DCIS Is Not Associated With Increased Cardiovascular Disease

Women who underwent radiation for ductal carcinoma in situ do not face an increased risk of cardiovascular disease, found a study presented at BCS 2013.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs